- Home
- HKD vs PLRX Comparison
HKD vs PLRX Comparison
Compare HKD & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKD
- PLRX
- Stock Information
- Founded
- HKD 2003
- PLRX 2015
- Country
- HKD France
- PLRX United States
- Employees
- HKD N/A
- PLRX N/A
- Industry
- HKD Finance: Consumer Services
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- HKD Finance
- PLRX Health Care
- Exchange
- HKD Nasdaq
- PLRX Nasdaq
- Market Cap
- HKD 503.4M
- PLRX 680.3M
- IPO Year
- HKD 2022
- PLRX 2020
- Fundamental
- Price
- HKD $2.67
- PLRX $11.37
- Analyst Decision
- HKD
- PLRX Strong Buy
- Analyst Count
- HKD 0
- PLRX 7
- Target Price
- HKD N/A
- PLRX $40.50
- AVG Volume (30 Days)
- HKD 254.0K
- PLRX 485.5K
- Earning Date
- HKD 01-01-0001
- PLRX 02-26-2025
- Dividend Yield
- HKD N/A
- PLRX N/A
- EPS Growth
- HKD N/A
- PLRX N/A
- EPS
- HKD 0.33
- PLRX N/A
- Revenue
- HKD $27,776,448.00
- PLRX N/A
- Revenue This Year
- HKD N/A
- PLRX N/A
- Revenue Next Year
- HKD N/A
- PLRX N/A
- P/E Ratio
- HKD $7.90
- PLRX N/A
- Revenue Growth
- HKD N/A
- PLRX N/A
- 52 Week Low
- HKD $2.55
- PLRX $10.22
- 52 Week High
- HKD $5.80
- PLRX $18.00
- Technical
- Relative Strength Index (RSI)
- HKD 39.72
- PLRX 44.60
- Support Level
- HKD $2.61
- PLRX $10.35
- Resistance Level
- HKD $2.95
- PLRX $11.07
- Average True Range (ATR)
- HKD 0.12
- PLRX 0.61
- MACD
- HKD -0.00
- PLRX 0.06
- Stochastic Oscillator
- HKD 6.41
- PLRX 43.50
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. The company integrates various digital businesses using its AMTD SpiderNet ecosystem. Its reportable segments are; digital solutions services financial services; digital solutions services non-financial services, hotel operations, hospitality and VIP services, digital media, content and marketing services, and others. The company generates maximum revenue by providing financial digital solutions through its AMTD Risk Solutions, a digital insurance brokerage platform, and PolicyPal which is a digital insurance technology platform. Geographically, the company generates maximum revenue from Hong Kong and the rest from Canada and Singapore.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.